Northwestern Mutual Wealth Management’s Ascendis Pharma A/S ASND Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.47K	Buy	13 +12	+1,200%	+$2.8K	﹤0.01%	3510
2026 Q1	$229	Sell	1 -9	-90%	-$2.02K	﹤0.01%	3927
2025 Q4	$2.13K	Buy	10 +4	+67%	+$826	﹤0.01%	3473
2025 Q3	$1.19K	Buy	+6	New	+$1.12K	﹤0.01%	3508

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Northwestern Mutual Wealth Management's ASND Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its Ascendis Pharma A/S (ASND) stake by 1,200% in Q2 2026, buying an estimated $2.8K and bringing the position to 13 shares worth $3.47K. The position accounts for ﹤0.01% of the portfolio, ranked #3510.

Northwestern Mutual Wealth Management first reported a position in ASND in Q3 2025 and has held it in 4 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Northwestern Mutual Wealth Management held 13 shares of Ascendis Pharma A/S worth $3.47K as of Q2 2026.
Northwestern Mutual Wealth Management bought 12 Ascendis Pharma A/S shares in Q2 2026, an estimated $2.8K.
Ascendis Pharma A/S made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3510 holding.
Northwestern Mutual Wealth Management first reported a position in Ascendis Pharma A/S in Q3 2025 and has held it in 4 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.